HeartBeam Inc. (NASDAQ: BEAT) has recently been granted two new U.S. patents, further cementing its role as a pioneer in the field of digital cardiac care. These patents cover the company’s compact, cable-free 3D ECG device and a sophisticated rhythm analysis algorithm, both designed to revolutionize how cardiac conditions are diagnosed and monitored outside traditional medical facilities.
The 3D ECG device stands out for its ability to collect high-fidelity cardiac signals from three non-coplanar directions using chest and finger electrodes. This innovation allows for on-demand symptom recording and the synthesis of 12-lead ECGs, offering a level of convenience and accuracy previously unattainable in remote settings. Currently under FDA review, the device’s software is supported by data from the VALID-ECG pivotal study, underscoring its potential to transform cardiac diagnostics.
Equally groundbreaking is the rhythm analysis algorithm, which enhances diagnostic precision by identifying arrhythmias through continuous signal input and triggering targeted data collection during abnormal rhythm detection. This technology is adaptable across various cardiac monitoring systems, promising to improve patient outcomes by enabling timely and accurate diagnoses.
With these latest additions, HeartBeam now holds 20 issued patents and has 34 more filings in progress, showcasing its commitment to innovation in cardiac care. The company’s future plans include integrating AI capabilities into its technologies to further enhance diagnostic accuracy, signaling a new era in personalized and accessible cardiac health management.
The implications of HeartBeam’s advancements are profound, offering the potential to significantly reduce the burden on healthcare systems by enabling early detection and management of cardiac conditions outside of hospitals. For patients, this means greater access to life-saving diagnostics, regardless of their location, marking a pivotal shift towards more democratized healthcare solutions.
This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is HeartBeam Inc. Advances Cardiac Care with New Patents for 3D ECG Technology.
